The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Open accessAbstract
Acetyl coenzyme A (AcCoA) is the central biosynthetic precursor for fatty-acid synthesis and protein acetylation. In the conventional view of mammalian cell metabolism, AcCoA is primarily generated from glucose-derived pyruvate through the citrate shuttle and ATP citrate lyase in the cytosol. However, proliferating cells that exhibit aerobic glycolysis and those exposed to hypoxia convert glucose to lactate at near-stoichiometric levels, directing glucose carbon away from the tricarboxylic acid cycle and fatty-acid synthesis. Although glutamine is consumed at levels exceeding that required for nitrogen biosynthesis, the regulation and use of glutamine metabolism in hypoxic cells is not well understood. Here we show that human cells use reductive metabolism of α-ketoglutarate to synthesize AcCoA for lipid synthesis. This isocitrate dehydrogenase-1 (IDH1)-dependent pathway is active in most cell lines under normal culture conditions, but cells grown under hypoxia rely almost exclusively on the reductive carboxylation of glutamine-derived α-ketoglutarate for de novo lipogenesis. Furthermore, renal cell lines deficient in the von Hippel-Lindau tumour suppressor protein preferentially use reductive glutamine metabolism for lipid biosynthesis even at normal oxygen levels. These results identify a critical role for oxygen in regulating carbon use to produce AcCoA and support lipid synthesis in mammalian cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both HIF-1α and HIF-2α activation promotes the upregulation of the glutamine transporter, SLC38A2, which increases the dependency of cells to glutamine and correlates with poorer survival in patients with breast cancer [58]”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredIn the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [631]
In the citing paper
“Citrate, generated by reductive carboxylation of α-KG, is especially crucial for lipid synthesis under low-oxygen conditions24,25.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [24]
In the citing paper
“and switch the fate of glutamine from the oxidative pathway into the reductive carboxylation pathway24.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [24]
In the citing paper
“In the context of constitutive HIF-2α stabilization75 or a defective mitochondrial electron transport chain76, glutamine-derived α-KG is reductively carboxylated through the consumption of NADPH by IDH2 to generate citrate.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [75]
In the citing paper
“Glutamine acts as an alternative fuel for fatty acid synthesis, supplying citrate via mitochondrial reductive carboxylation, especially under hypoxic conditions74,75.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [75]
In the citing paper
“Alternatively, proliferating cells under hypoxia have been reported to predominantly reductively carboxylate glutamine generated α-ketoglutarate through IDH 1/2 to generate M5 citrate (Figure 4A) (Metallo, 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Metallo, 2012
In the citing paper
“Previous reports showed that reductive carboxylation is a critical pathway to support the growth of tumor cells under hypoxia (Metallo, 2012; Mullen, 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Metallo, 2012
In the citing paper
“The upregulation of the reductive carboxylation pathway enhances cancer cells proliferation (Metallo, 2012; Mullen, 2012; Wise et al., 2011).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Metallo, 2012
In the citing paper
“For example, under conditions of hypoxia or impaired mitochondrial respiration, certain reactions of the TCA cycle reverse to support glutamine-dependent reductive carboxylation (92, 122, 123).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [122]
In the citing paper
“In a process referred to as reductive carboxylation, a section of the TCA cycle reverses itself, converting α-ketoglutarate into citrate, which can be then used to generate a source of cytosolic acetyl-CoA (Metallo et al., 2012; Wise et al., 2011).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Metallo et al., 2012
In the citing paper
“Citrate is generated by citrate synthase (CS) or through the reduction of α-ketoglutarate by isocitrate dehydrogenase (IDH).79–81”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [79]
In the citing paper
“Citrate levels, however, were markedly decreased in Mpc1KD or Mpc2KD (Mpc1/2KD) cells, as this metabolite is generated predominantly from pyruvate-derived AcCoA under normal growth conditions (Metallo et al., 2012).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Metallo et al., 2012
In the citing paper
“Glutamine can contribute carbon to fatty acid synthesis via reductive carboxylation or oxidative glutaminolysis.”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Metallo et al., 2012
In the citing paper
“The former pathway is highly active in cells proliferating under hypoxia or those with a compromised respiratory chain (Metallo et al., 2012; Mullen et al., 2012; Scott et al., 2011; Wise et al., 2011), while the latter pathway has been observed in B cell lymphoma (Le et al., 2012).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Metallo et al., 2012
In the citing paper
“This switch to reductive versus oxidative metabolism of α-KG is regulated in part by HIF-1α (71, 72), although the exact mechanism by which HIF-1α does so remains unclear.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [71]
In the citing paper
“Although oxidation of glutamine-derived α-KG in the TCA cycle serves as a minor source of lipogenic acetyl-CoA under normal growth conditions, α-KG can be converted to citrate through reductive carboxylation under conditions of stress such as hypoxia or mitochondrial dysfunction (70–72).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [71]
In the citing paper
“The work from Metallo and colleagues (71) suggests that T cells can use reductive glutamine metabolism for fatty acid biosynthesis under hypoxic conditions.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [71]
In the citing paper
“In place of oxidative metabolism of both glucose and glutamine, these cancers preferentially perform reductive and carboxylating biosynthetic reactions from glutamine carbon (Le et al., 2012; Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Metallo et al., 2012
In the citing paper
“Recently three independent reports implicated IDH-dependent reductive carboxylation as playing a particularly important role in proliferating cells that exhibit decreased flux of glucose-derived pyruvate into the mitochondria. This occurs in hypoxic cells or in cells harboring defects in mitochondrial oxidative phosphorylation (Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Metallo et al., 2012
In the citing paper
“tumor cells with mutations in the TCA cycle or ETC (Mullen et al., 2011), or with hypoxia-induced suppression of oxidative metabolism (Metallo et al., 2011; Scott et al., 2011; Wise et al., 2011) use reductive carboxylation of α-KG to produce citrate and other precursors during growth.”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Metallo et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“The von Hippel–Lindau (VHL) tumour suppressor protein is frequently lost in renal cell carcinoma (RCC) and results in a state of ‘pseudohypoxia’ by activating HIF signallin”
BackgroundKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
T cell receptor antagonist peptides induce positive selection.
Hogquist, K., Jameson, S., Heath, W., Howard, J. L., Bevan, M., & Carbone, F. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 3,252
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
ATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Cited by
Sorted by citations
Items 701–800 of 1,003
Worth, A. J., Basu, S. S., Snyder, N. W., Mesaros, C., & Blair, I. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.591354 · Cited by 54
MicroRNA‐23b downregulates peroxiredoxin III in human prostate cancer
He, H., Zhu, J., Chen, X.-B., Chen, S.-M., Han, Z., Dai, Q.-S., Ling, X., Fu, X., Lin, Z., Deng, Y.-H., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.003 · Cited by 53
Wang, J., Zhang, P., Zhong, J., Tan, M., Ge, J., Tao, L., Li, Y., Zhu, Y., Wu, L., Qiu, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8382 · Cited by 55
Increased Dynamics of Tricarboxylic Acid Cycle and Glutamate Synthesis in Obese Adipose Tissue
Nagao, H., Nishizawa, H., Bamba, T., Nakayama, Y., Isozumi, N., Nagamori, S., Kanai, Y., Tanaka, Y., Kita, S., Fukuda, S., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.770172 · Cited by 53
Wrzesinski, K., & Fey, S. J. (2018) · Bioengineering · doi:10.3390/bioengineering5010022 · Cited by 55
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
Läsche, M., Emons, G., & Gründker, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00409 · Cited by 55
Singleton, D. C., Dechaume, A.-L., Murray, P. M., Katt, W. P., Baguley, B. C., & Leung, E. Y. (2020) · BMC Cancer · doi:10.1186/s12885-020-06885-3 · Cited by 56
Dheeraj, A., Agarwal, C., Schlaepfer, I. R., Raben, D., Singh, R. P., Agarwal, R., & Deep, G. (2018) · Hypoxia · doi:10.2147/hp.s163115 · Cited by 52
N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages
Menga, A., Favia, M., Spera, I., Vegliante, M. C., Gissi, R., Grassi, A., Laera, L., Campanella, A., Gerbino, A., Carrà, G., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051981 · Cited by 57
Emberley, E. D., Pan, A., Chen, J., Dang, R., Gross, M. I., Huang, T. C., Li, W., MacKinnon, A. L., Singh, D., Sotirovska, N., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259241 · Cited by 54
Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 57
Targeting the glutamine-arginine-proline metabolism axis in cancer
Wang, D., Duan, J., Guo, Y., Chen, J., Chen, T.-Q., Wang, J., & Yu, S. (2024) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2024.2367129 · Cited by 56
Mamer, O., Gravel, S., Choinière, L., Chénard, V., St‐Pierre, J., & Avizonis, D. Z. (2013) · Metabolomics · doi:10.1007/s11306-013-0521-1 · Cited by 52
Ogawa, T., Washio, J., Takahashi, T., Echigo, S., & Takahashi, N. (2014) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2014.04.003 · Cited by 53
A role for vaccinia virus protein C16 in reprogramming cellular energy metabolism
Mazzon, M., Castro, C., Roberts, L. D., Griffin, J. L., & Smith, G. L. (2014) · Journal of General Virology · doi:10.1099/vir.0.069591-0 · Cited by 53
Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
Chakraborty, P. K., Xiong, X., Mustafi, S. B., Saha, S., Dhanasekaran, D. N., Mandal, N. A., McMeekin, S., Bhattacharya, R., & Mukherjee, P. (2015) · Oncotarget · doi:10.18632/oncotarget.5424 · Cited by 51
NMR-based Stable Isotope Resolved Metabolomics in systems biochemistry
Lane, A. N., & Fan, T. W. ‐. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.02.009 · Cited by 54
Chen, C., Tang, Q., Zhang, Y., Dai, M., Jiang, Y., Wang, H., Yu, M., Jing, W., & Tian, W. (2017) · Cell Proliferation · doi:10.1111/cpr.12363 · Cited by 53
Glutamine metabolism in cancer therapy
Nguyen, T.-L., & Durán, R. V. (2018) · Cancer Drug Resistance · doi:10.20517/cdr.2018.08 · Cited by 56
Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy
Bergaggio, E., & Piva, R. (2019) · Cancers · doi:10.3390/cancers11040563 · Cited by 52
Brown Fat as a Regulator of Systemic Metabolism beyond Thermogenesis
Okamatsu‐Ogura, Y., & Saito, M. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0291 · Cited by 55
Mitochondrial redox adaptations enable alternative aspartate synthesis in SDH-deficient cells
Hart, M. L., Quon, E., Vigil, A.-L. B. G., Engström, I., Newsom, O. J., Davidsen, K., Hoellerbauer, P., Carlisle, S. M., & Sullivan, L. B. (2023) · eLife · doi:10.7554/elife.78654 · Cited by 50
Zhang, Y., Higgins, C. B., Tica, S., Adams, J. A., Sun, J., Kelly, S. C., Zong, X., Dietzen, D. J., Pietka, T., Ballentine, S. J., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.007 · Cited by 50
Hypoxia and Metabolism in Cancer
Bensaad, K., & Harris, A. L. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_1 · Cited by 49
Yang, X., Du, T., Wang, X., Zhang, Y., Hu, W., Du, X., Miao, L., & Han, C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.027 · Cited by 51
Glutamate as chemotactic fuel for diffuse glioma cells: Are they glutamate suckers?
van Lith, S. A. M., Navis, A. C., Verrijp, K. N., Niclou, S. P., Bjerkvig, R., Wesseling, P., Tops, B. B. J., Molenaar, R. J., Noorden, C. J. F. V., & Leenders, W. P. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.004 · Cited by 51
Siegel, D. J., Permentier, H. P., Reijngoud, D., & Bischoff, R. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.11.022 · Cited by 51
MicroRNAs and the Warburg Effect: New Players in an Old Arena
Gao, P., Sun, L., He, X., Cao, Y., & Zhang, H. (2012) · Current Gene Therapy · doi:10.2174/156652312802083620 · Cited by 51
Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers
Bledea, R., Vasudevaraja, V., Patel, S. V., Stafford, J. M., Serrano, J., Esposito, G., Tredwin, L. M., Goodman, N. E., Kloetgen, A., Golfinos, J. G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53262-7 · Cited by 52
Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies
de Wit, S., Glen, C., de Boer, R. A., & Lang, N. N. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac132 · Cited by 54
Exploring metabolic pathways that contribute to the stem cell phenotype
Vacanti, N. M., & Metallo, C. M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.007 · Cited by 51
Self-citationBrose, S. A., Marquardt, A. L., & Golovko, M. Y. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12617 · Cited by 53
Immunometabolism: A new target for improving cancer immunotherapy
Guo, C., Chen, S., Liu, W., Ma, Y., Li, J., Fisher, P. B., Fang, X., & Wang, X. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.004 · Cited by 56
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Nelson, B. S., Lin, L., Kremer, D. M., Sousa, C. M., Cotta‐Ramusino, C., Myers, A. L., Ramos, J., Gao, T., Kovalenko, I., Wilder-Romans, K., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-019-0202-2 · Cited by 51
Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective
Gentric, G., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13030399 · Cited by 52
Bejoy, J., Yuan, X., Song, L., Hua, T., Jeske, R., Sart, S., Sang, Q. A., & Li, Y. (2019) · Stem Cells International · doi:10.1155/2019/2382534 · Cited by 52
Shabgah, A. G., Norouzi, F., Hedayati‐Moghadam, M., Soleimani, D., Pahlavani, N., & Navashenaq, J. G. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00552-5 · Cited by 49
Transporters at the Interface between Cytosolic and Mitochondrial Amino Acid Metabolism
Hewton, K. G., Johal, A. S., & Parker, S. J. (2021) · Metabolites · doi:10.3390/metabo11020112 · Cited by 52
Acetyl-CoA and Metabolite Fluxes Regulate White Adipose Tissue Expansion
Felix, J. B., Cox, A. R., & Hartig, S. M. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.008 · Cited by 52
Eleftheriadis, T., Pissas, G., Antoniadi, G., Spanoulis, A., Liakopoulos, V., & Stefanidis, I. (2014) · International Immunology · doi:10.1093/intimm/dxu077 · Cited by 50
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk
Morandi, A., Giannoni, E., & Chiarugi, P. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.11.001 · Cited by 50
The potential of breath analysis to improve outcome for patients with lung cancer
Antoniou, S., Gaude, E., Ruparel, M., van der Schee, M. P., Janes, S. M., & Rintoul, R. C. (2019) · Journal of Breath Research · doi:10.1088/1752-7163/ab0bee · Cited by 49
Cook, K. M., Shen, H. M., McKelvey, K. J., Gee, H. E., & Hau, E. K. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147265 · Cited by 55
Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer
Saggese, P., Sellitto, A., Martinez, C. A., Giurato, G., Nassa, G., Rizzo, F. M., Tarallo, R., & Scafoglio, C. (2020) · Cancers · doi:10.3390/cancers12123788 · Cited by 46
Koritzinsky, M., & Wouters, B. G. (2013) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2013.05.006 · Cited by 50
Glutamine at focus: versatile roles in cancer
Vitto, H. D., Pérez-Valencia, J. A., & Radosevich, J. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-4671-9 · Cited by 54
Metabolic reprogramming in the pathogenesis of glioma: Update
Masui, K., Onizuka, H., Cavenee, W. K., Mischel, P. S., & Shibata, N. (2019) · Neuropathology · doi:10.1111/neup.12535 · Cited by 48
Three-Dimensional Graphene Enhances Neural Stem Cell Proliferation Through Metabolic Regulation
Fang, Q., Zhang, Y., Chen, X., Li, H., Cheng, L., Zhu, W., Zhang, Z., Tang, M., Liu, W., Wang, H., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00436 · Cited by 48
A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma
Cheng, G., Liu, D., Liang, H., Yang, H., Chen, K., & Zhang, X. (2019) · Aging · doi:10.18632/aging.102407 · Cited by 47
Helenius, I. T., Madala, H. R., & Yeh, J.-R. J. (2021) · Biomolecules · doi:10.3390/biom11111666 · Cited by 43
Kiweler, N., Delbrouck, C., Pozdeev, V. I., Neises, L., Soriano‐Baguet, L., Eiden, K., Xian, F., Benzarti, M., Haase, L., Koncina, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30363-y · Cited by 46
Amino Acids in Cancer and Cachexia: An Integrated View
Ragni, M., Fornelli, C., Nisoli, E., & Penna, F. (2022) · Cancers · doi:10.3390/cancers14225691 · Cited by 48
AKT-independent activation of p38 MAP kinase promotes vascular calcification
Yang, Y., Sun, Y., Chen, J., Bradley, W. E., Dell’Italia, L. J., Wu, H., & Chen, Y. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.009 · Cited by 47
Ying, M., Guo, C., & Hu, X. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007841 · Cited by 45
Shaping of Dendritic Cell Function by the Metabolic Micro-Environment
Brombacher, E. C., & Everts, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00555 · Cited by 45
Li, S., Yin, Y., Clark, L. H., Sun, W., Sullivan, S. A., Tran, A.-Q., Han, J., Zhang, L., Guo, H., Madugu, E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18854 · Cited by 46
Madala, H. R., Punganuru, S. R., Arutla, V., Misra, S., Thomas, T., & Srivenugopal, K. S. (2018) · Cancers · doi:10.3390/cancers10020049 · Cited by 46
Shah, R., Singh, S. J., Eddy, K., Filipp, F. V., & Chen, S. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1500 · Cited by 47
Qian, Y., Huang, R., Li, S., Xie, R., Qian, B., Zhang, Z., Li, L., Wang, B., Tian, C., Yang, J., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.2a0419-117r · Cited by 46
Self-citationConnecting Metabolic Rewiring With Phenotype Switching in Melanoma
Falletta, P., Goding, C. R., & Vivas, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.930250 · Cited by 46
Metabolic adaptations of cancer in extreme tumor microenvironments
Nakahara, R., Maeda, K., Aki, S., & Osawa, T. (2023) · Cancer Science · doi:10.1111/cas.15722 · Cited by 47
NMDA Receptor and Its Emerging Role in Cancer
Gallo, S., Vitacolonna, A., & Crepaldi, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032540 · Cited by 47
Glutamine transporter SLC38A3 promotes breast cancer metastasis via Gsk3β/β-catenin/EMT pathway
Tan, Z., Boyapati, K., Tressler, C. M., Jenkinson, N. M., & Glunde, K. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216653 · Cited by 46
Lipid metabolism in cancer: Exploring phospholipids as potential biomarkers
Delmas, D., Mialhe, A., Cotte, A. K., Connat, J., Bouyer, F., Hermetet, F., & Aires, V. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118095 · Cited by 49
Dehne, N., & Brüne, B. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4776 · Cited by 44
Pietzke, M., Zasada, C., Mudrich, S., & Kempa, S. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-9 · Cited by 47
Acetate metabolism in cancer cells
Hosios, A. M., & Heiden, M. G. V. (2014) · Cancer & Metabolism · doi:10.1186/s40170-014-0027-y · Cited by 45
Mitochondrial Uncoupling and the Reprograming of Intermediary Metabolism in Leukemia Cells
Vélez, J., Hail, N., Konopleva, M. Y., Zeng, Z., Kojima, K., Samudio, I. J., & Andreeff, M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00067 · Cited by 50
Kuo, C., Lin, C., & Hsu, T. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3196 · Cited by 46
Badur, M. G., & Metallo, C. M. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.11.013 · Cited by 44
Self-citationKumar, A. A., Giri, S., & Shaha, C. (2018) · FEBS Journal · doi:10.1111/febs.14406 · Cited by 47
Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin
Flores, A., Sandoval-Gonzalez, S., Takahashi, R., Krall, A. S., Sathe, L., Wei, L., Radu, C. G., Joly, J. H., Graham, N. A., Christofk, H. R., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07857-9 · Cited by 45
High ammonia exposure regulates lipid metabolism in the pig skeletal muscle via mTOR pathway
Tang, S., Xie, J., Wu, W., Yi, B., Liu, L., & Zhang, H. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139917 · Cited by 45
Bacigalupa, Z. A., & Rathmell, W. K. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.034 · Cited by 47
Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring
Scalise, M., Console, L., Rovella, F., Galluccio, M., Pochini, L., & Indiveri, C. (2020) · Cells · doi:10.3390/cells9092028 · Cited by 45
Tumor circulating DNA profiling in xenografted mice exposed to intermittent hypoxia
Cortese, R., Almendros, I., Wang, Y., & Gozal, D. (2014) · Oncotarget · doi:10.18632/oncotarget.2785 · Cited by 46
Deamidation Shunts RelA from Mediating Inflammation to Aerobic Glycolysis
Zhao, J., Tian, M., Zhang, S. J., Delfarah, A., Gao, R., Rao, Y., Savas, A. C., Lu, A., Bubb, L., Lei, X., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.006 · Cited by 44
Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression
Barnabas, G. D., Lee, J. S., Shami, T., Harel, M., Beck, L., Selitrennik, M., Jerby‐Arnon, L., Erez, N., Ruppin, E., & Geiger, T. (2021) · Cancer Research · doi:10.1158/0008-5472.can-19-3020 · Cited by 45
Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme
Esteban-Amo, M. J., Jiménez-Cuadrado, P., Serrano‐Lorenzo, P., de la Fuente, M. Á., & Simarro, M. (2024) · Biomedicines · doi:10.3390/biomedicines12092050 · Cited by 51
Action at a Distance: Allostery and the Development of Drugs to Target Cancer Cell Metabolism
DeLaBarre, B., Hurov, J., Cianchetta, G., Murray, S., & Dang, L. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.007 · Cited by 45
Kasinskas, R. W., Venkatasubramanian, R., & Forbes, N. S. (2014) · Integrative Biology · doi:10.1039/c4ib00001c · Cited by 44
Cancer Cells Hijack Gluconeogenic Enzymes to Fuel Cell Growth
Balsa-Martinez, E., & Puigserver, P. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.11.005 · Cited by 44
ACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate
Keenan, M. M., Liu, B., Tang, X., Wu, J., Cyr, D. D., Stevens, R. D., Ilkayeva, O., Huang, Z., Tollini, L. A., Murphy, S. K., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005599 · Cited by 43
Vallée, A., Vallée, J.-N., & Lecarpentier, Y. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.05.024 · Cited by 46
Guo, Z., Pan, F., Peng, L., Tian, S., Jiao, J., Liao, L., Lu, C., Zhai, G., Wu, Z., Dong, H., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002150 · Cited by 45
Shi, Y. X., Dou, Y., Zhang, J., Qi, J., Xin, Z., Zhang, M., Xiao, Y. P., & Ci, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.737498 · Cited by 45
Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy
Gu, X., Liu, Y., Dai, X., Yang, Y., & Zhang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1137107 · Cited by 43
Stress eating and tuning out: Cancer cells re-wire metabolism to counter stress
Stine, Z. E., & Dang, C. V. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.844093 · Cited by 44
Changes in muscle proteomics in the course of the Caudwell Research Expedition to Mt. Everest
Levett, D. Z. H., Viganò, A., Capitanio, D., Vasso, M., Palma, S. D., Moriggi, M., Martín, D., Murray, A. J., Cerretelli, P., Grocott, M. P. W., et al. (2014) · PROTEOMICS · doi:10.1002/pmic.201400306 · Cited by 43
Alberghina, L., Gaglio, D., Gelfi, C., Moresco, R. M., Mauri, G., Bertolazzi, P., Messa, C., Gilardi, M. C., Chiaradonna, F., & Vanoni, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00362 · Cited by 45
Hwang, V. J., Kim, J., Rand, A. A., Yang, C., Sturdivant, S., Hammock, B. D., Bell, P. D., Guay‐Woodford, L. M., & Weiss, R. H. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00238.2015 · Cited by 43
Bridging the gap between non-targeted stable isotope labeling and metabolic flux analysis
Weindl, D., Cordes, T., Battello, N., Sapcariu, S. C., Dong, X., Wegner, A., & Hiller, K. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0150-z · Cited by 43
Self-citationSanders, E. B., & Diehl, S. (2015) · Oncoscience · doi:10.18632/oncoscience.128 · Cited by 43
Mitochondrial dysfunction and potential anticancer therapy
LLeonart, M. E., Grodzicki, R., Graifer, D. M., & Lyakhovich, A. (2017) · Medicinal Research Reviews · doi:10.1002/med.21459 · Cited by 43
Metabolic Signaling to Epigenetic Alterations in Cancer
Kim, J., & Yeom, Y. I. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.185 · Cited by 45
Fujisawa, K., Takami, T., Okada, S., Hara, K., Matsumoto, T., Yamamoto, N., Yamasaki, T., & Sakaida, I. (2018) · Stem Cells · doi:10.1002/stem.2826 · Cited by 44
The Fate of Glutamine in Human Metabolism. The Interplay with Glucose in Proliferating Cells
Mazat, J., & Ransac, S. (2019) · Metabolites · doi:10.3390/metabo9050081 · Cited by 44
Arima, K., Lau, M. C., Zhao, M. M., Haruki, K., Kosumi, K., Mima, K., Gu, M., Väyrynen, J. P., Twombly, T. S., Baba, Y., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-1091 · Cited by 43
Hypoxia, hypoxia-inducible gene 2 (HIG2)/HILPDA, and intracellular lipolysis in cancer
Povero, D., Johnson, S. M., & Liu, J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.013 · Cited by 46
Metabolic Flux Analysis—Linking Isotope Labeling and Metabolic Fluxes
Wang, Y., Wondisford, F. E., Song, C. W., Zhang, T., & Su, X. (2020) · Metabolites · doi:10.3390/metabo10110447 · Cited by 44
Metadata
- Authors
- Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., Kelleher, J. K., Vander Heiden, M. G., Iliopoulos, O., & Stephanopoulos, G.
- Affiliations
- Massachusetts Institute of Technology (US)
- Massachusetts General Hospital (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Iliopoulos, Othon
- Stephanopoulos, Gregory
- ORCID
- Venue
- Nature
- Published
- 2011-11-20
- Volume
- 481
- Issue
- 7381
- Pages
- 380-384
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3710581
- OpenAlex
- W2116516144
- Cited by
- 1,791
- References
- 43
- Citations by year
- 2026: 82 · 2025: 95 · 2024: 96 · 2023: 137 · 2022: 156 · 2021: 143 · 2020: 149 · 2019: 125 · 2018: 100 · 2017: 135 · 2016: 129 · 2015: 125 · 2014: 119 · 2013: 112 · 2012: 84
- FWCI
- 34.61
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- RePEc: Research Papers in Economics (submittedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Damon Runyon Cancer Research Foundation
- Wellcome Trust
- Agios Pharmaceuticals
- National Institutes of Health
- National Cancer Institute (R01CA160458, R01CA122591, P30CA014051)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK075850)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- IDH1, lipogenesis, hypoxia, reductive carboxylation, alpha-ketoglutarate, acetyl-CoA, fatty acid synthesis, VHL, renal cell carcinoma, cancer metabolism, mitochondrial dysfunction, aerobic glycolysis
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Acetyl Coenzyme A, Carbon, Carcinoma, Renal Cell, Cells, Cultured, Citric Acid Cycle, Glutamine, Humans, Isocitrate Dehydrogenase, Ketoglutaric Acids, Kidney Neoplasms, Oxidation-Reduction, Oxygen, Cell Hypoxia, CD8-Positive T-Lymphocytes, Palmitic Acid, Cell Line, Tumor, Lipogenesis, Aryl Hydrocarbon Receptor Nuclear Translocator, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
